María Calbacho

2.7k total citations
33 papers, 400 citations indexed

About

María Calbacho is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, María Calbacho has authored 33 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 12 papers in Oncology and 11 papers in Genetics. Recurrent topics in María Calbacho's work include Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). María Calbacho is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). María Calbacho collaborates with scholars based in Spain, United States and Italy. María Calbacho's co-authors include Matthias Stelljes, Naohito Fujishima, Partow Kebriaei, Ryan D. Cassaday, Elias Jabbour, Anjali S. Advani, Daniel J. DeAngelo, Anna Ejduk, Erik Vandendries and Akil Merchant and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

María Calbacho

27 papers receiving 393 citations

Peers

Countries citing papers authored by María Calbacho

Since Specialization

Citations

This map shows the geographic impact of María Calbacho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Calbacho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Calbacho more than expected).

Fields of papers citing papers by María Calbacho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Calbacho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Calbacho. The network helps show where María Calbacho may publish in the future.

Co-authorship network of co-authors of María Calbacho

This figure shows the co-authorship network connecting the top 25 collaborators of María Calbacho. A scholar is included among the top collaborators of María Calbacho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Calbacho. María Calbacho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breakthrough Invasive Mold Infections in Hematologic Cases: Relevance of the Host's Factors 2025 ·Open Forum Infectious Diseases ·Isabel Rodríguez‐Góncer, (unknown), (unknown), José María Sánchez‐Pina, Manuel Lizasoaín, Mario Fernández‐Ruiz, Rafael San Juan, Francisco López‐Medrano, Ana Pérez‐Ayala, (unknown), Joaquín Martínez‐López, José María Aguado, María Calbacho	0
2	Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma 2025 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ana Carla Oliveira, Tycho Baumann, (unknown), Carlos Grande, (unknown), (unknown), (unknown), Rosa Ayala, María Calbacho, Joaquín Martínez‐López, Santiago Barrio, Ana Jiménez Ubieto	0
3	Financial toxicity in allogeneic haematopoietic stem cell transplant patients from a social determinants of health perspective 2024 ·European Journal of Oncology Nursing ·(unknown), (unknown), (unknown), (unknown), Mi Kwon, (unknown), María Calbacho, Ana Royuela, Pilar Serrano‐Gallardo	2
4	Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH) 2024 ·Transplantation and Cellular Therapy ·Ignacio Gómez‐Centurión, (unknown), (unknown), (unknown), Anabelle Chinea, (unknown), Alexandra Pedraza, (unknown), María Calbacho, Rebeca Bailén, (unknown), (unknown), (unknown), Alejandro Luna, (unknown), Montserrat Rovira, Anna Torrent, José María Sánchez‐Pina, Mi Kwon	0
5	Engaging Innate Immunity By AFM28, an Innate Cell Engager (ICE®) Targeting CD123-Positive Leukemic Cells in Patients with Relapsed/Refractory Acute Myeloid Leukemia: Safety and Efficacy Results of a First-in-Human Phase 1 Study 2024 ·Blood ·Pau Montesinos, Montserrat Arnán, Stéphane de Botton, María Calbacho, (unknown), Pierre Bories, Belén Ansoleaga, Thomas Hueso, Naval Daver, Lydia Wunderle, A. Harstrick, (unknown), (unknown), (unknown), Tania Witte, Eugene L. Saenger, Christian Récher	3
6	Treatment with Siltuximab for Short Term Complications after Chimeric Antigen Receptor T-Cell Therapy: A Multicenter Retrospective Analysis 2024 ·Blood ·José María Sánchez‐Pina, (unknown), Lucía López‐Corral, Anabelle Chinea, (unknown), Núria Martínez‐Cibrián, Rafael Hernani, Víctor Noriega, (unknown), Pascual Balsalobre, María Calbacho, (unknown), Pere Barba, Mi Kwon	0
7	Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network 2022 ·Blood Cancer Journal ·(unknown), Rosa Ayala, Gema Hernández, (unknown), (unknown), (unknown), (unknown), Gonzalo Carreño‐Tarragona, José María Sánchez‐Pina, Rafael Alonso, Noelia García Barrio, David Pérez-Rey, (unknown), María Calbacho, Jaime Cruz‐Rojo, Miguel Pedrera‐Jiménez, Pablo Serrano Balazote, Javier de la Cruz, Joaquín Martínez‐López	5
8	Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia 2022 ·PubMed ·Joaquín Martínez‐López, Pau Montesinos, (unknown), Rosa Ayala, Pilar Martínez‐Sánchez, (unknown), (unknown), (unknown), (unknown), María Calbacho, (unknown), Josè Antonio Pérez-Simón, Adolfo de la Fuente, Jaime Pérez de Oteyza, Rebeca Rodríguez‐Veiga, (unknown), Blanca Boluda, Isabel Cano, (unknown), Juan Ballesteros	2
9	Updated results from DIAMOND-01 (CLI24-001) trial: A phase I/II study of SEL24/MEN1703, a first-in-class dual PIM/FLT3 kinase inhibitor, in acute myeloid leukemia. 2021 ·Journal of Clinical Oncology ·Scott R. Solomon, Pau Montesinos, Aziz Nazha, Stephen A. Strickland, Giovanni Martinelli, Armando Santoro, Roland B. Walter, Rachel J. Cook, María Calbacho, Susana Vives, Salman Fazal, Krzysztof Brzózka, Setareh Shamsili, (unknown), Dirk Laurent, Andrea Pellacani, Farhad Ravandi	3
10	Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant 2021 ·Frontiers in Immunology ·Rebeca Bailén, José L. Vicário, Laura Solán, (unknown), Pilar Herrera, María Calbacho, Raquel Alenda, José Luis López Lorenzo, (unknown), Anabelle Chinea, José María Sánchez‐Pina, A. Balas, Miguel Ángel Moreno, (unknown), (unknown), Nieves Dorado, (unknown), Javier Anguita, José L. Díez‐Martín, Mi Kwon	14
11	Impact of COVID-19 in patients with multiple myeloma based on a global data network 2021 ·Blood Cancer Journal ·Joaquín Martínez‐López, Gema Hernández, (unknown), José María Sánchez‐Pina, (unknown), (unknown), (unknown), (unknown), María Calbacho, (unknown), Rosa Ayala, Noelia García Barrio, David Pérez-Rey, (unknown), (unknown), Miguel Pedrera‐Jiménez, Pablo Serrano Balazote, Javier de la Cruz	24
12	Trombosis senovenosa cerebral en un recién nacido con mutación MTHFR C677T tratado con enoxaparina 2020 ·Revista chilena de pediatría ·(unknown), María Calbacho, (unknown), (unknown), (unknown), Alfredo García‐Alix	1
13	Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study 2017 ·The Lancet Haematology ·Hagop M. Kantarjian, Daniel J. DeAngelo, Anjali S. Advani, Matthias Stelljes, Partow Kebriaei, Ryan D. Cassaday, Akil Merchant, Naohito Fujishima, Toshiki Uchida, María Calbacho, Anna Ejduk, Susan O’Brien, Elias Jabbour, Hui Zhang, Barbara Sleight, Erik Vandendries, David I. Marks	138
14	Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy 2015 ·Leukemia & lymphoma ·(unknown), David Gallardo, José González‐Campos, Jesús María Hernández‐Rivas, Pau Montesinos, Josep Sarrà, Cristina Gil, Pere Barba, Ramón Guàrdia, Salut Brunet, Teresa Bernal, (unknown), Eugènia Abella, (unknown), (unknown), Antònia Cladera, Jorge Gayoso, María Calbacho, Josep‐María Ribera, (unknown)	11
15	Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts 2014 ·Annals of Hematology ·Patricia Font, Javier Loscertales, Carlos Soto, Pilar Ricard, (unknown), (unknown), (unknown), Luis García‐Alonso, (unknown), (unknown), Celina Benavente, Mónica Ballesteros, María‐Teresa Cedena, María Calbacho, (unknown), Jesús Villarrubia, Santiago Gil, José M. Bellón, José L. Díez‐Martín, Ana Villegas	50
16	Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia 2014 ·Platelets ·Tomás José González‐López, Blanca Sánchez‐González, Cristina Pascual, (unknown), Erik de Cabo, Arancha Alonso, Mónica Martín‐Salces, (unknown), María Calbacho, Pilar Galán, Abelardo Bárez, José Ramón González‐Porras	15
17	Cytogenetics Findings in a Histiocytic Sarcoma Case 2012 ·SHILAP Revista de lepidopterología ·Juan Manuel Alonso‐Domínguez, María Calbacho, María Talavera, (unknown), (unknown), Valentín García‐Gutiérrez, Sara Lozano, (unknown), Jesús Villarrubia, Javier López‐Jiménez, Maria Teresa Ferrò	5
18	Impact of Second-Generation Tyrosine Kinase Inhibitors As Second Line Treatment for Patients with Chronic Myeloid Leukemia, 2011 ·Blood ·Valentín García‐Gutiérrez, Pilar Herrera, (unknown), (unknown), María Calbacho, (unknown), (unknown), Carlos Montalbán, Javier López‐Jiménez	12
19	Clofarabine-Based Chemotherapy for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. the Spanish Experience 2011 ·Blood ·Pere Barba, Antònia Sampol, María Calbacho, José González, Josefina Serrano, (unknown), Pascual Fernández, Raimundo García‐Boyero, Rodrigo Martino, Pilar Delgado, José‐Ángel Hernández‐Rivas, Eloy del Potro, (unknown), (unknown), Adolfo de la Fuente, Javier Bueno, Josep‐María Ribera	1
20	Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group 2010 ·Haematologica ·Francisco Cervantes, (unknown), M. Montero, (unknown), Jesús Martı́nez, Juan Carlos Hernández‐Boluda, María Calbacho, Anna Sureda, Gloria Pérez‐Rus, José Nieto, Carlos Pérez‐López, José Román‐Gómez, Marcos González, Arturo Pereira, Dolors Colomer	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact